Evidence map›Paper›PMID 39632339›Full record

ArticleJournal of immunotoxicology2024

Assessment of dermal sensitization by nickel salts in a novel humanized TLR-4 mouse model.

K A Roach, S E Anderson, C Waggy, J Aldinger, A B Stefaniak, J R Roberts

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunotoxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

K A RoachAllergy and Clinical Immunology Branch (ACIB), National Institute of Occupational Safety and Health (NIOSH), Morgantown, WV, USA.
S E AndersonAllergy and Clinical Immunology Branch (ACIB), National Institute of Occupational Safety and Health (NIOSH), Morgantown, WV, USA.
C WaggyOffice of the Director, NIOSH, Morgantown, WV, USA.
J AldingerAllergy and Clinical Immunology Branch (ACIB), National Institute of Occupational Safety and Health (NIOSH), Morgantown, WV, USA.
A B StefaniakRespiratory Health Division, NIOSH, Morgantown, WV, USA.
J R RobertsAllergy and Clinical Immunology Branch (ACIB), National Institute of Occupational Safety and Health (NIOSH), Morgantown, WV, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

The fundamental goal of this study was to determine the potential utility of a novel humanized Toll-like receptor-4 (hTLR-4) mouse model for future

Indexed as

Disease Models, AnimalImmunoglobulin ENickelToll-Like Receptor 4AnimalsCytokinesDermatitis, Allergic ContactFemaleHumansLocal Lymph Node AssayLymph NodesMaleMiceMice, TransgenicSkinCytokinesImmunoglobulin ENickelnickel sulfateTLR4 protein, humanToll-Like Receptor 4allergy modelhypersensitivitylocal lymph node assayNickelsensitizationtoll-like receptor-4

Identifiers

PMID39632339
PMCPMC11664636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.